Looking for Device Contract Manufacturing Organizations? | |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| 
| July 2, 2009 |
| Thanks to Lead SoCalBio Sponsor |  |
SoCalBio-Recommended Seminars | Behind the Logo
Successful Brand Strategies:
An Interactive Seminar Series Offered by  This is a must-attend series of seminars on business branding strategies for innovators and entrepreneurs. These seminars are delivered by Sasha Strauss (photo right), an award-winning speaker and graduate professor of brand strategy at USC who regularly guest lectures at top business schools such as MIT, Cornell, Columbia, UCLA Anderson and USC Marshall. Brand development strategy and methodology will be presented from previous work delivered for the world's most powerful brands, from Adobe and Microsoft to Johnson & Johnson and
eBay... For dates and to RSVP, click here |
Coming in July | July 9, 5:00 - 9:00 pm (California Club in downtown LA) July
29, 4:00 - 7:00 pm (Ernst & Young's Office in downtown LA)  SoCalBio Networking Forum in Los Angeles : "Bioscience Business Models Beyond the Current Systemic Funding Drought"
|
Patnering | Woodland Hills-Base ImmunoCellular Therapeutics Signs Manufacturing Agreement with Formatech for Clinical Trial of ICT-121 Immunotherapy The Phase I clinical trial of ICT-121 will target glioblastoma (brain cancer) and is expected to begin early next year, pending clearance by the FDA. ICT-121 is an "off-the-shelf" product, and this agreement calls for Formatech to prepare the vials of cancer vaccine for the clinical trial under a GMP (Good Manufacturing Practices) environment ... Read more |
Licensing | Calando Pharmaceuticals of Pasadena Licenses Its Drug Delivery Platform to Cerulean Pharma Inc. The agreement is part of Calando's strategy to minimize its burn rate while retaining upside exposure via partnerships with high quality companies that will continue the development of Calando's platforms and drug candidates.... Read more |
Clinical Data | Aliso Viejo-Based Vertos Medical's Minimally Invasive Lumbar Decompression (MILD) Procedure Gets Nod from Leading Physicians Among the key data unveiled were comparative Oswestry Disability Index
(ODI) scores from an initial mild clinical study and from a published study on open surgical treatment for lumbar spinal
stenosis. These data indicated that mild patients showed excellent improvement at three months post-op compared to open surgery patients at 12 months post-op. mild patients also showed impressive improvement in Visual Analog Scale (VAS) scores at three months post-op... Read more |
Financing | Irvine-Based Spectrum Pharmaceuticals to Raise $21 Million from Institutional Investors at $7.15 Per Share Proceeds from the transaction will be used for general corporate purposes. The offering is expected to be consummated no later than July 6, 2009, subject to customary closing conditions. Rodman &
Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., acted as the exclusive placement agent for the transaction ... Read more |
New Products | Irvine-Based Ista Pharmaceuticals Wins U.S. Panel Support for Eye Itch Drug A proposed drug from Ista Pharmaceuticals Inc
(ISTA.O) won unanimous support from a U.S. advisory panel on Friday for treating itchiness in the eye caused by allergies... Read more Caldera Medical of Agoura Hills Announces FDA Clearance of Novel Treatment for Pelvic Organ Prolapse Pelvic Organ Prolapse is one of the most common quality of life conditions facing women. In fact, nearly 50% of women who have given birth vaginally will develop this condition. Ascend enables treatment of both anterior and apical prolapse in a single procedure..... Read more Can Spectrum Pharmaceuticals Benefit from FDA Action on
Zevalin? Author contends that, despite the fact that Spectrum's Zevalin has been demonstrated as safe and effective treatments for patients with relapsed or refractory non-Hodgkin's lymphoma for years, fewer than 10% of patients who are candidates for this product ever receive it... Click here to know the reason why |
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
Editor: